Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Cognitive Deficits in Multiple Sclerosis
NCT00638833Phase 2Terminated
- Sponsor
- Universidad de Navarra
- Start
- Sep 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in multiple sclerosis (MS), sponsored by Universidad de Navarra. Started Sep 2007; status: terminated.
02
Drugs
memantine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00638833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638833.